Atlas Trials

Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma

Clinical trial NCT00078455 · COMPLETED

Trial details

NCT number
NCT00078455
Sponsor
Genzyme, a Sanofi Company
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small-Cell Lung Carcinoma
Start date
2003-12-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.